Fig. 4From: What’s happening where when SARS-CoV-2 infects: are TLR7 and MAFB sufficient to explain patient vulnerability?Resensitization of the TLR7-signaling pathway leads to a skewed cytokine response with a missing IFN response due to repression of IFN expression by high levels of the BZIP transcription factor MAFB, a known antagonist of antiviral responsesBack to article page